This is a working overview of RP-HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-26. Anything still debated is marked as such rather than presented as settled.
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatographic profiles reveal related impurities, truncated sequences, and oxidation products, while mass measurement confirms the expected molecular mass. Purity values for research material are typically reported as a percentage by peak area. Reference standards help calibrate retention behavior across instruments. Independent laboratories emphasize method suitability because results depend heavily on column chemistry, gradient, and detection wavelength. Batch-to-batch comparison relies on the same validated method.
Investigational peptide material is commonly distributed as a lyophilized powder in sealed vials. The solid form appears as a white to off-white cake or powder and is hygroscopic once opened. Peptides of this size are sensitive to moisture, repeated freeze-thaw cycles, and prolonged exposure to ambient light. Handling practices therefore emphasize desiccation, minimal vial opening, and cold storage. Working aliquots are often prepared to avoid repeatedly warming the bulk container.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Not a small molecule |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist activity |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also in aqueous buffers |
| Storage | −20 °C or below | Protect from light and moisture |
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Characterising a peptide of this size relies on a combination of chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the intact molecule from related impurities, while electrospray mass spectrometry confirms molecular mass and detects truncation or oxidation products. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates modified residues. Because the molecule carries a lipid chain, assays must also distinguish the correctly conjugated product from incompletely acylated species.
Laboratory handling follows the conventions used for other synthetic peptides. Lyophilized material is weighed and dissolved in an aqueous diluent, typically sterile water or bacteriostatic water, using gentle swirling rather than vigorous shaking, because foaming stresses the chain. Solutions are prepared under clean conditions and, where sterility matters, passed through a suitable filter. Working portions are kept small so that stock material is not repeatedly warmed and cooled, a practice that limits both aggregation and gradual loss of activity.
Stability depends strongly on physical state. Dry powder is comparatively robust when held at -20 °C or below, desiccated and shielded from light; under those conditions degradation is slow and measured over years. Once dissolved, the peptide becomes far more vulnerable: backbone hydrolysis, oxidation of susceptible residues and aggregation all proceed faster in solution, and the rates climb with temperature and with pH far from neutral. Refrigerated storage at 2–8 °C extends usable life for short periods, and repeated freeze–thaw cycles are best avoided.
Will Self, novelist (Jewish mother); son of Peter Self, and grandson of Sir Albert Henry Self Charles Gabriel Seligman FRS FRAI (né Seligmann; 24 December 1873 – 19 September 1940) was author, scholar, academic, physician and ethnologist; main ethnographic work described culture of Vedda people of Sri Lanka and Shilluk people of Sudan; was professor at London School of Economics; influential as the teacher of Bronisław Malinowski, E. E. Evans-Pritchard, and Meyer Fortes; was proponent of the Hamitic hypothesis, according to which some civilisations of Africa were thought to have been founded by Caucasoid Hamitic peoples. His work in the 1920s and 1930s is now seen as "white supremacist". Nicholas Serota (born 27 April 1946), author, art historian and curator; served as Director of the Tate from 1988 to 2017; currently Chair of Arts Council England; was previously Director of The Museum of Modern Art, Oxford, and Director of the Whitechapel Gallery, before becoming Director of the Tate; was also Chairman of the Turner Prize jury. Malcolm Shaw (academic) KC (born 1947), British legal academic, author, editor and lawyer; studied at University of Liverpool (LLB), Hebrew University of Jerusalem (LLM) and Keele University (PhD); was the Sir Robert Jennings Professor of International Law at the University of Leicester and taught international law, human rights and equity and trusts; appointed as Senior Fellow at Lauterpacht Centre for International Law at University of Cambridge; Trustee of the British Institute of International and Comparative Law.
company was sold to Cardinal Health and the Canadian company was sold to an investor group. Today the technology of the U.S. company is controlled by Abbott Laboratories (2007) and the Canadian company was acquired by Cerner Corp. (2013)
== Pharmacokinetics == Before clinical testing, a new class of therapeutic agent has to be characterized in terms of preclinical metabolism and excretion studies. Average bioavailability is found to be around 60–65%. Aprepitant is metabolized primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19. Seven metabolites of aprepitant, which are only weakly active, have been identified in human plasma. As a moderate inhibitor of CYP3A4, aprepitant can increase plasma concentrations of co-administered medicinal products that are metabolized through CYP3A4. Specific interaction has been demonstrated with oxycodone, where aprepitant both increased the efficacy and worsened the side effects of oxycodone; however it is unclear whether this is due to CYP3A4 inhibition or through its NK1 antagonist action. Following IV administration of a 14C-labeled prodrug of aprepitant (L-758298), which is converted rapidly and completely to aprepitant, approximately 57% of the total radioactivity is excreted in the urine and 45% in feces. No unchanged substance is excreted in urine.
The premise of CAR-T immunotherapy is to modify T cells to recognize cancer cells in order to target and destroy them. Scientists harvest T cells from people, genetically alter them to add a chimeric antigen receptor (CAR) that specifically recognizes cancer cells, then infuse the resulting CAR-T cells into patients to attack their tumors. Tisagenlecleucel (Kymriah), a chimeric antigen receptor (CAR-T) therapy, was approved by the FDA in 2017 to treat acute lymphoblastic leukemia (ALL). This treatment removes CD19 positive cells (B-cells) from the body (including the diseased cells, but also normal antibody-producing cells). Axicabtagene ciloleucel (Yescarta) is another CAR-T therapeutic, approved in 2017 for treatment of diffuse large B-cell lymphoma (DLBCL).
The high fiber content provides water-absorbing and water-binding capabilities. Organic acids such as sorbitol act as humectants, provide dough and batter stability, and control water activity. Fruit sugars add sweetness, humectancy, and surface browning, and control water activity. Fruit acids, such as malic acid and tartaric acid, contribute to flavor enhancement. The high drying and processing temperatures, the intrinsic low pH of the fruit, and the low water activity (moisture content) in dried fruit make them a stable food.
Sources: en.wikipedia.org
The advent of global decolonisation and the subsequent rise in prominence of the Soviet Union among several newly independent African states was viewed with wariness by the South African government. National Party politicians began warning it would be only a matter of time before they were faced with a Soviet-directed insurgency on their borders. Outlying regions in South West Africa, namely the Caprivi Strip, became the focus of massive SADF air and ground training manoeuvres, as well as heightened border patrols. A year before SWAPO made the decision to send its first SWALA recruits abroad for guerrilla training, South Africa established fortified police outposts along the Caprivi Strip for the express purpose of deterring insurgents. When SWALA cadres armed with Soviet weapons and training began to make their appearance in South West Africa, the National Party believed its fears of a local Soviet proxy force had finally been realised. The Soviet Union took a keen interest in Africa's independence movements and initially hoped that the cultivation of socialist client states on the continent would deny their economic and strategic resources to the West. Soviet training of SWALA was thus not confined to tactical matters but extended to Marxist–Leninist political theory, and the procedures for establishing an effective political-military infrastructure. In addition to training, the Soviets quickly became SWALA's leading supplier of arms and money.
mitotic index (MI) The proportion of cells within a sample which are undergoing mitosis at the time of observation, typically expressed as a percentage or as a value between 0 and 1. The number of cells dividing by mitosis at any given time can vary widely depending on organism, tissue, developmental stage, and culture media, among other factors.
== Physiology == Although not yet completely understood, the dawn phenomenon is thought to be caused by an exaggeration of the normal physiologic hormonal processes that occur overnight. Overnight, the human body sees increased levels of several hormones, most notably growth hormone and catecholamines, that lead to increased rates of glucose production and release from the liver. These hormones also inhibit the effects of insulin, leading to an overall increase in circulating blood glucose. This effect is amplified in patients with islet β-cell dysfunction such as diabetics. Notably throughout this process glucagon levels remain unchanged and the increased levels of cortisol observed overnight do not appear to be involved. Observed hyperglycemia secondary to the dawn phenomenon is often defined as an increase in blood glucose of at least >1.1 mmol/L (20 mg/dL) between the lowest level at night and the highest level before breakfast; however, actual ranges may vary. The physiologic process involved in causing the dawn phenomenon has been shown to occur in most people. In non-diabetic patients, there is a modest increase in insulin secretion just before dawn which compensates for the increased glucose being released from the liver to prevent hyperglycemia. However, studies have shown that diabetic patients fail to compensate for this transiently increased blood glucose release, resulting in hyperglycemia. This resulting hyperglycemia is clinically relevant in diabetic patients as its lasting effects can lead to overall poor glycemic control.
There are three flat skeletal muscles in the antero-lateral wall of the abdomen. The external oblique, closest to the surface, extend inferiorly and medially, in the direction of sliding one’s four fingers into pants pockets. Perpendicular to it is the intermediate internal oblique, extending superiorly and medially, the direction the thumbs usually go when the other fingers are in the pants pocket. The deep muscle, the transversus abdominis, is arranged transversely around the abdomen, similar to the front of a belt on a pair of pants. This arrangement of three bands of muscles in different orientations allows various movements and rotations of the trunk. The three layers of muscle also help to protect the internal abdominal organs in an area where there is no bone.
Sources: en.wikipedia.org
=== Pregnancy and lactation === Use of tramadol during pregnancy is generally avoided, as it may cause some reversible withdrawal effects in the newborn. A small prospective study in France found, while an increased risk of miscarriages existed, no major malformations were reported in the newborn. Its use during lactation is also generally advised against, but a small trial found that infants breastfed by mothers taking tramadol were exposed to about 2.88% of the dose the mothers were taking. No evidence of this dose harming the newborn was seen.
== January == 1 January to 31 August Operation Rice Farmer was a U.S. 9th Infantry Division and Army of the Republic of Vietnam (ARVN) 5th Division operation in Dinh Tuong, Kien Tuong and Kien Hoa Provinces. The operation resulted in 1,860 PAVN/VC killed.
== Prizes and honours == 1997, 1999 Merit scholarship to study Medical Laboratory Technology at Institute of Medicine, Tribhuvan University 2005 Gallwas membership Grant, AACC 2005 and 2007 International travel grant, AACC 2006 Young Achievers Award 2007 International Travel Grant, Asian & Pacific Federation of Clinical Biochemistry (APFCB) 2008 and 2010 KNU Honors Scholarship for Graduation Study (MS and PHD) 2012 Featured member of AACC, interview published at AACC website 2013 KNU Best Publication Award 2014 KNU Cell-Matrix Research Institute Winter Seminar Award
Sources: en.wikipedia.org
Retatrutide is an investigational synthetic peptide that activates three metabolic receptors: GLP-1, GIP, and glucagon. It is being studied for obesity and type 2 diabetes. It has not been approved for clinical use.
Earlier incretin therapies engage one or two receptors. Retatrutide adds glucagon receptor activity, which may raise energy expenditure. Whether this produces larger clinical benefits is still being tested.
It has completed phase 2 trials and moved into later-stage evaluation. No regulator has granted approval. Access outside research settings is not authorized.
Solid powder is held frozen at -20 °C or below in a desiccated container. Reconstituted solutions are refrigerated and used within a limited period.